Those with a personal or family history of thyroid cancer or thyroid tumors
The lack of regulation around microdosing is exactly why it is considered high risk, with dosing errors and contamination being two key areas of concern
Medical patches are indicated for other issues, like hormone replacement therapy, infertility, smoking cessation, and morebut some medical experts caution that the GLP-1 patches can be misleading
PlexusDx pairs its semaglutide and tirzepatide protocols with upstream genetic insight from the Precision Peptide Genetic Test
Polyphenols and certain spice compounds work through yet other pathways including inhibiting DPP-IV, the enzyme that breaks GLP-1 down within minutes of its release
Conclusion: A Thoughtful Approach to Innovation GLP-1 microdosing represents an intriguing development in metabolic medicine, offering the potential for personalized treatment with reduced side effects